Overview

Efficacy and Tolerability of Angeliq in Thai Women

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety, tolerability, and efficacy of Angeliq in Thai post menopausal women with hot flushes and other climacteric symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Drospirenone and ethinyl estradiol combination
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate